2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole
C90H106N24O13 — CID 165091747
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole
2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole (PubChem CID 165091747) has the molecular formula C90H106N24O13 and a molecular weight of 1731.99 g/mol. Its IUPAC name is 2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole.
Molecular Properties
| Compound Name | 2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole |
|---|---|
| PubChem CID | 165091747 |
| Molecular Formula | C90H106N24O13 |
| Molecular Weight | 1731.99 g/mol |
| Exact Mass | 1730.84 |
| IUPAC Name | 2-[(5-carbamoyl-3-pyridinyl)amino]-2-oxoacetic acid;methane;5-[[2-[(2S,5R)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide;bis(5-[[2-[(2R,5S)-5-methyl-2-(7-methyl-1H-indazol-5-yl)piperidin-1-yl]-2-oxoacetyl]amino]pyridine-3-carboxamide);7-methyl-5-[(2R,5S)-5-methylpiperidin-2-yl]-1H-indazole |
| SMILES | C.C.Cc1cc([C@@H]2CC[C@@H](C)CN2C(=O)C(=O)Nc2cncc(C(N)=O)c2)cc2cn[nH]c12.Cc1cc([C@H]2CC[C@H](C)CN2)cc2cn[nH]c12.Cc1cc([C@H]2CC[C@H](C)CN2C(=O)C(=O)Nc2cncc(C(N)=O)c2)cc2cn[nH]c12.Cc1cc([C@H]2CC[C@H](C)CN2C(=O)C(=O)Nc2cncc(C(N)=O)c2)cc2cn[nH]c12.NC(=O)c1cncc(NC(=O)C(=O)O)c1 |
| InChI | InChI=1S/3C22H24N6O3.C14H19N3.C8H7N3O4.2CH4/c3*1-12-3-4-18(14-5-13(2)19-15(6-14)9-25-27-19)28(11-12)22(31)21(30)26-17-7-16(20(23)29)8-24-10-17;1-9-3-4-13(15-7-9)11-5-10(2)14-12(6-11)8-16-17-14;9-6(12)4-1-5(3-10-2-4)11-7(13)8(14)15;;/h3*5-10,12,18H,3-4,11H2,1-2H3,(H2,23,29)(H,25,27)(H,26,30);5-6,8-9,13,15H,3-4,7H2,1-2H3,(H,16,17);1-3H,(H2,9,12)(H,11,13)(H,14,15);2*1H4/t3*12-,18+;9-,13+;;;/m1000.../s1 |
| InChIKey | WVCPDFIHPLPACS-OINLKVNUSA-N |
| XLogP | 10.32 |
| TPSA | 565.30 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1731.99 |
| LogP ≤ 5 | 10.32 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165091747 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.